Foundation: | 2001 |
Purpose: | The program, called Renal
Discoveries*, was designed to promote scientific discoveries in the field of kidney disease. Supporting the study of all aspects of kidney disease from pathophysiology to treatment options, Renal Discoveries provides much needed resources to enable researchers and clinical investigators to pursue the broad long-term studies that are critical to enhancing knowledge of kidney disease and its treatment.
|
Scholarships: |
|
Funding: | Baxter |
Reviewers: | ISN and
Baxter work together to determine potential research topics, which will be announced twice each year, along with detailed writing instructions to guide applicants through the process. An independent medical advisory board will evaluate applications based on scientific merit. Baxter selects board members from among ISNs membership. Board members will periodically rotate to ensure breadth of scientific judgment. |
Topics | Treatment of severe congestive heart failure with peritoneal dialysis
proposals and writing instructions
|
Deadlines:
|
Application
deadline is 1 September 2003. |
For more information on Renal Discoveries and instructions for grant applications, please visit www.baxter.com/egp
|
*Renal Discoveries is a trademark of
Baxter International Inc.
Robert C. Atkins, MBBS, MSc, DSc, FRACPClayton, Victoria, Australia
Tilman B. Dr?eke, MD Paris, France
David C.H. Harris, MD, BS, FRACPWestmead, NSW, Australia
J. Harold Helderman, MD, FACPNashville,
TN, USA
Lee W. Henderson, MD, FACPGuilford, CT, USA
Walter H. H?rl, MD, PhD, FRCPVienna, Austria
Saulo Klahr, MDSt. Louis, MO, USA
William E. Mitch, MDAtlanta, GA, USA
Sarah S. Prichard, MD, FRCP(C)Montreal, Quebec, Canada
Peter Stenvinkel, MD, PhDStockholm, Sweden